Compare AbCellera Biologics Inc (ABCL) vs InMode Ltd (INMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs InMode Ltd — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while InMode Ltd trades at $15.16 (market cap $872.08M). The key difference: AbCellera Biologics Inc is far larger — about 3.4× InMode Ltd's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.
| ABCL | INMD | |
|---|---|---|
Market Cap | $2.99B | $872.08M |
Sector | Health | Technology |
52-Week High | $9.76 | $16.62 |
52-Week Low | $2.78 | $12.76 |
Enterprise Value | $2.58B | $375.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →
